Takeda’s oral TYK2 inhibitor showed rapid skin clearance in phase 3 psoriasis trials as FDA fast-tracks review; decision expected early 2027.
News|Poll|January 18, 2017
Erosive Dermatits, Arthritis, and Urethritis: Dx?
Author(s)Jonathan A. Schneider, DO
This serious symptom constellation is seen in a 21-year-old man. Is it familiar to you?
Advertisement
A 21-year-old male with a history of chronic aphthous mouth ulcers is seen with a diffuse severe erosive dermatitis accompanied by arthritis; he also has genitourinary symptoms suggestive of urethritis and ocular signs associated with vitritis and retinal vasculitis.
Taken together the elements of this presentation point to which of the following?
Advertisement
Related to this article
Advertisement
Advertisement
Trending on Patient Care Online
1
ASH Raises Ferritin Thresholds for Diagnosing Iron Deficiency
2
Elevated PSA in Primary Care: What to Consider Before Biopsy
3
FDA Grants Priority Review to Zasocitinib for Plaque Psoriasis
4
FDA Clears Beta Bionics’ Mint Reusable Insulin Patch Pump
5